Carbon Monoxide Poisoning Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Safety Study of Inhaled Carbon Monoxide to Treat Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS)
Conditions: Acute Respiratory Distress Syndrome; Sepsis Interventions: Drug: Inhaled Carbon Monoxide at CFK equation-determined personalized dose (200-500 ppm to achieve a COHb level of 6-8%); Other: Inhaled Medical air Sponsors: Brigham and Women's Hospital; Weill Medical College of Cornell University; Massachusetts General Hospital; Duke University; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2021 Category: Research Source Type: clinical trials

Safety Study of Inhaled Carbon Monoxide to Treat Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS)
Conditions: Acute Respiratory Distress Syndrome; Sepsis Interventions: Drug: Inhaled Carbon Monoxide at CFK equation-determined personalized dose (200-500 ppm to achieve a COHb level of 6-8%); Other: Inhaled Medical air Sponsors: Brigham and Women's Hospital; Weill Medical College of Cornell University; Massachusetts General Hospital; Duke University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2021 Category: Research Source Type: clinical trials

A Comparison of Exhaled Carbon Monoxide Measurements Using the iCOquit Smokerlyzer and Vitalograph Breath CO Monitor vs Carboxyhemoglobin From Venous Samples While Validating a Mobile Research Application
Condition: Smoking, Cigarette Intervention: Sponsors: Rose Research Center, LLC; Foundation for a Smoke-Free World Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2021 Category: Research Source Type: clinical trials